Components of

Polio Vaccine

Components Page
Excipients Table
Allergens Table
Name IPOL
Manufacturer Sanofi Pasteur  
Viability Inactivated
Indicated Ages 6 weeks - 6 years  
Dose 0.5 mL  
Schedule 4 doses at 2, 4, 6-18 months and 4-6 years  
Route Intramuscular
Appearance Clear and colorless  
Concentration Type 1 poliovirus (Mahoney), 40 D antigen units
Type 2 poliovirus (MEF-1), 8 D antigen units
Type 3 poliovirus (Saukett), 32 D antigen units
 
Preservative • 2-phenoxyethanol, 0.5%
• Formaldehyde, 0.02%
 
Adjuvant None
Excipients • 2-phenoxyethanol, 0.5%
• Formaldehyde, ≤0.02%
• Neomycin, <5 ng
• Streptomycin, 200ng
• Polymyxin B, 25 ng
• Calf bovine serum albumin, <50 ng
Allergens • Neomycin, <5 ng
• Streptomycin, 200ng
• Polymyxin B, 25 ng
Media • Each strain grown individually in VERO cells
• Cells grown in Eagle MEM modified medium (supplemented with newborn calf bovine serum)
• Culture medium for viral growth replaced by M-199 (without calf bovine serum)
 
Packaging Vial containing ten 0.5 mL doses  
Storage 2-8°C (35-46°F)
PI date August 2015  
  table last updated 1/2/19